Skyline Biosciences

Skyline Biosciences is developing therapies to treat premalignant and malignant oral lesions. It helps patients with oral oncology conditions.
TypeSubsidiary
Parent CompanyParagon Biosciences
HQChicago, US
Founded2018
Websiteskylinebiosciences.com
Cybersecurity ratingAMore
Skyline Biosciences was founded in 2018 and is headquartered in Chicago, US

Viewing summary data as a guest

Sign up for free to see all data

Skyline Biosciences Office Locations

Skyline Biosciences has an office in Chicago
Chicago, US (HQ)
330 N Wabash Ave #3500
Show all (1)

Skyline Biosciences Financials and Metrics

Summary Metrics

Founding Date

2018
Skyline Biosciences is a subsidiary of Paragon Biosciences

Skyline Biosciences Cybersecurity Score

Cybersecurity ratingPremium dataset

A

97/100

SecurityScorecard logo

Skyline Biosciences Online and Social Media Presence

Embed Graph

Skyline Biosciences Frequently Asked Questions

  • When was Skyline Biosciences founded?

    Skyline Biosciences was founded in 2018.

  • How many employees does Skyline Biosciences have?

    Skyline Biosciences has 1 employees.

  • Who are Skyline Biosciences competitors?

    Competitors of Skyline Biosciences include Retrophin, Palatin Technologies and Melinta Therapeutics.

  • Where is Skyline Biosciences headquarters?

    Skyline Biosciences headquarters is located at 330 N Wabash Ave #3500, Chicago.

  • Where are Skyline Biosciences offices?

    Skyline Biosciences has an office in Chicago.

  • How many offices does Skyline Biosciences have?

    Skyline Biosciences has 1 office.